Synopsys at $460: Appealing Ahead of Dec. 8 Earnings

Synopsys (NASDAQ:SNPS | SNPS Price Prediction) trades at $459.95, a price below where the stock started the year even though earnings estimates keep rising ahead of its fiscal fourth-quarter report.

Synopsys leads the market for electronic design automation (EDA), the software chipmakers use to design and verify chips, and it also licenses silicon IP. Its ~$35B Ansys acquisition extended the company into simulation, covering everything from silicon to full systems. The shares have dropped 9.81% over the past month and remain well below the 52-week high of $539.48.

Raised Guidance and a 25x Forward Multiple Power the Bull Case

Third-quarter revenue reached $2.48B, up 42.4%. Non-GAAP EPS of $3.91 exceeded the $3.67 consensus, and that was the 4th straight beat. Management then raised full-year guidance to a $15.07 non-GAAP EPS target. The stock trades at a forward P/E of 25, compared with a trailing figure of 83.

Analysts have made 14 upward revisions to fiscal 2027 EPS in the past 30 days, bringing the average to $18.6455. Design IP grew roughly 11%, and management expects Multiphysics Fusion to add to EDA growth in 2027. CEO Sassine Ghazi said “EDA is accelerating. Design IP has returned to growth and Ansys is performing strongly.”

Debt, Amortization and Post-Earnings Selloffs Fuel the Bear Case

Synopsys carries approximately $10 billion of debt. About $404M of intangible assets amortization each quarter weighs on GAAP results, and GAAP net income in the second quarter fell to just $17.1M. Company filings also flag shareholder lawsuits over Design IP disclosures, a Morgan Stanley downgrade warning of slowing growth, and export control risk tied to China.

Beating estimates has often failed to lift the shares. After the third-quarter beat, the stock rose 13.39% on the day and then gave back 10.45% over the following week. Backlog slid to $10.9 billion from the prior quarter.

Fiscal 2027 Guidance Will Settle the Debate

Fourth-quarter non-GAAP EPS guidance from management came in at $4.10–$4.16, with consensus at $4.1332. The fiscal 2027 outlook matters more than the quarter itself. Investors will look for double-digit EDA growth, sequential IP gains and progress on licensing-plus-royalty deals before committing either way.

Analysts See 28% Upside as Shares Trail the S&P 500

The average analyst target of $589.55 implies 28.2% upside from $459.95. Targets are estimates and carry no guarantee. Of the 25 analysts covering the stock:

• Strong Buy: 3
• Buy: 20
• Hold: 2
• Sell: 0

So far this year, Synopsys is down 2.08% while the S&P 500 is up 9.99%. Over one year, Synopsys has gained 14.77%, ahead of the index at 10.06%.

Synopsys Heads Into Its Fourth-Quarter Report With Rising Estimates

At $459.95, several factors shape the outlook for Synopsys.

The stock trades at roughly 25 times fiscal 2027 consensus EPS, yet analysts keep raising that number. Management has beaten estimates for four quarters in a row, and the fourth-quarter consensus sits inside guidance. That leaves room for another beat.

The path higher depends on fiscal 2027 guidance that shows EDA acceleration and early revenue from Multiphysics Fusion and the more than 30 agentic AI projects now underway. Free cash flow of about $2.6B keeps paying down debt, which should ease the main bear concern over the next several quarters.

The investment thesis falls apart if fiscal 2027 guidance points to slowing EDA growth, or if Design IP slips again. Past post-earnings swings mean volatility is likely, and the stock has already fallen 9.81% over the past month. The shares currently reflect accelerating AI-driven earnings at a multiple that already prices in plenty of doubt.

Contact [email protected] for any questions or corrections.